News | Artificial Heart | September 13, 2016

SynCardia Artificial Heart to Emerge from Chapter 11 Reorganization With New Owner

Court-approved plan will see business sold to Sindex by Sept. 16 of this year

SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart

August 29, 2016 — SynCardia Systems, manufacturer of the Total Artificial Heart (TAH), announced that the judge overseeing its Chapter 11 reorganization has approved the conditions for the bankruptcy process.

The judge approved the following:

  1. The court approved for SynCardia the retention of its professionals, debtor in possession financing and bid procedures;
  2. The second order provides SynCardia with access to money to continue to make purchases and operate in its normal course; and
  3. The last order entered provides for the sale of the business to Sindex. The court, after hearing all the arguments, granted a workable and reasonable time table for the business to be marketed and sold in the near-term, with a sale date of Sept. 16, 2016.

SynCardia said its plans for the future remain unchanged. They include the following initiatives:

  1. Complete the next generation of Freedom portable driver, which will be smaller, lighter and virtually silent. The Freedom driver powers SynCardia Total Artificial Hearts and provides patients with nearly unlimited mobility;
  2. Complete the U.S. Food and Drug Administration (FDA)-approved 50cc TAH-t clinical study in the United States. The 50cc is a smaller version of SynCardia 70cc TAH-t and fits women, adolescents and men of smaller stature. The 50cc TAH-t has already been approved for use in Europe;
  3. Complete the FDA-approved destination therapy clinical study in the United States for patients who are not transplant eligible; and
  4. Expand the availability of the SynCardia Total Artificial Heart to underserved populations and geographies.

The International Society for Heart and Lung Transplantation (ISHLT) recently issued the first annual report of its Mechanically Assisted Circulatory Support (IMACS) registry. The global registry monitors the outcomes of patients receiving durable mechanical circulatory support (MCS) devices in all countries and hospitals wishing to participate.

According to the latest statistics in the IMACS report, 73.5 percent of patients implanted with the SynCardia Artificial Heart were either alive on the device (26.3 percent) or were transplanted (47.2 percent) at six months. This is the highest bridge-to-transplant rate for any durable device.

For more information:

Related Content

Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Hospital Readmissions Analysis Across All Ages, Insurance Types Identifies High-Risk Groups
News | Business| July 20, 2017
July 20, 2017 — Clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) recently published a first-of-i
Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Overlay Init